C-THC Antigen [BSA]

CTHC Antigen, BSAConjugated DAG3100 chemosynchetic Lot. No. (See product label) PRODUCT INFORMATION Product overview CTHC Antigen, BSAConjugated Antigen Description Metabolites are the intermediates and products of metabolism. The term metabolite is usually restricted to small molecules. Metabolites have various functions, including fuel, structure, signaling, stimulatory and inhibitory effects on enzymes, catalytic Description CTHC Antigen, BSAConjugated Species chemosynchetic Conjugate BSA Form Liquid in distilled water Applications immunogen Usage For Research or Further Manufacturing Use Only Not for Use in Diagnostic Procedures PACKAGING Storage Short Term: Refrigerate at 28°C; Long Term: Freeze at 20°C; Avoid repeated freezethaw cycles Concentration 3.73 mg/ml BACKGROUND Introduction Tetrahydrocannabinol (tetrəhydrəkənabinol; THC), also knownas delta9tetrahydrocannabinol (Δ9THC), Δ1THC (usingan older chemicalnomenclature),or dronabinol, is the main psychoactive substance found inthe cannabis plant. Itwas first isolated in 1964. In pure form, it is a glassysolid when cold, and becomes viscous and stickyif warmed. An aromatic terpenoid, THC has avery low solubility in water, but good solubility in mostorganic solvents.Like mostpharmacologicallyactive secondary metabolites of plants,THC in cannabis is assumedto be involved in selfdefense, perhaps against herbivores. THCalso possesses high UVB (280315 nm) absorption properties, which,it has been speculated, could protect the plant from harmful UV radiationexposure. Keywords Tetrahydrocannabinol; THC; Deltanyne; DeltaTHC; Ganja; Hashish; 6HDibenzo;9delta Tetrahydrocannabinol; Cannabis resin; delta(sup 1)thc; delta(sup9)tetrahydrocannabinol; delta9 tetrahydrocannabinol ethanol*solutiondea;delta9tetrahydrocannabinol me REFERENCES 1. McKim, William A (2002). Drugs and Behavior: An Introduction to Behavioral Pharmacology (5th ed.). Prentice Hall. p. 400. ISBN 0130481181. 2. Greenberg, Gary (20051101). "Respectable Reefer". Mother Jones. Retrieved 8 April 2010. 3. Calhoun, SR; Galloway, GP; Smith, DE (1998). "Abuse potential of dronabinol (Marinol)". Journal of Psychoactive Drugs 30 (2): 187–96. Creative Diagnostics. All rights reserved 4516 Ramsey Road Shirley, NY 11967, USA Tel: 6316244882 ·Fax:6316147828 Email: info@creativediagnostics.com www.creativediagnostics.com